Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues

  • Mary Ellen SandersEmail author
  • Jos Huis in’t Veld


Properly formulated probiotic-containing foods offer consumers a low risk, low cost dietary component that has the potential to promote health in a variety of ways. Several such products are available commercially, although markets in Japan and Europe are more developed than in the USA. Once healthful attributes of a probiotic product have been identified, there remain microbiological, product, regulatory and labeling issues to be addressed prior to marketing. Microbiological and product issues include safety, effective scale-up for manufacturing, definition of probiotic activity, probiotic stability in the product over the course of product manufacture, shelf-life and consumption, definition of effective dose and target population(s), and development of quality assurance approaches. Examples of probiotic-containing foods are given. Regulatory and labeling issues are complicated because they differ for each country, but are likewise critical because they provide the means for communication of the product benefits to the consumer. The regulatory climate worldwide appears to be one of caution about overstating the benefits of such products but at the same time not preventing corporate commitment to marketing.


Lactic Acid Bacterium Dietary Supplement Functional Food Probiotic Bacterium Probiotic Strain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams MR and Marteau P (1995) On the safety of lactic acid bacteria from food. Int. J. Food Microbiol. 27: 263–264PubMedCrossRefGoogle Scholar
  2. Aguirre M and Collins MD (1993) Lactic acid bacteria and human clinical infection. J. Appl. Bacteriol. 75: 95–107PubMedCrossRefGoogle Scholar
  3. Anon. (1996) Is yogurt the health food it’s cracked up to be? Tufts Univ. Diet Nutr. Let. November, pp. 3–5Google Scholar
  4. Anon. (1998) FDA denies numerous structure/function claims. Food Regulation Weekly, Nov. 23, 1998Google Scholar
  5. Arthur M and Courvalin P (1993) Genetics and mechanisms of glycopeptide resistance in enterococci. A minireview. Antimicrob. Agents Chemother. 37: 1563–1571PubMedCrossRefGoogle Scholar
  6. Arthur M, Reynolds P and Courvalin P (1996) Glycopeptide resistance in enterococci. Trends in Microbiol. 4: 401–407CrossRefGoogle Scholar
  7. Aso Y and Akazan H (1992) Prophylactic effect of Lactobacillus ca-sei preparation on the recurrence of superficial bladder cancer. BLP study group. Urol. Int. 49: 125–129PubMedCrossRefGoogle Scholar
  8. Berner LA and O’Donnell JA (1998) Functional foods and health claims legislations: applications to dairy foods. Int. Dairy J. 8: 355–362CrossRefGoogle Scholar
  9. Canganella F, Paganini S, Ovidi M, Vettraino AM, Bevilacqua L, Massa S and Trovatelli LD (1997) A microbiological investigation on probiotic pharmaceutical products used for human health. Microbiol. Res. 152: 171–179Google Scholar
  10. Collins JK, Thornton G and Sullivan GO (1998) Selection of probiotic strains for human applications. Int. Dairy J. 8: 487–490Google Scholar
  11. Donohue DC, Deighton M, Ahokas JT and Salminen S (1993) Toxicity of lactic acid bacteria. In: Salminen and von Wright (Eds.) Lactic Acid Bacteria. (pp 307–313 ). Marcel Dekker, Inc., New YorkGoogle Scholar
  12. Dunne C, Murphy L, Flynn S, O’Mahony L, O’Halloran S, Feeney M, Morrisey D, Thornton G, Fitzgerald G, Daly C, Kiely B, Quigley EMM, O’Sullivan GC, Shanahan F and Collins JK (1999) Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. These proceedings.Google Scholar
  13. Fonden R, Mogensen G, Tanaka R and Salminen S (1999) Effect of fermented dairy products on intestinal microflora, human nutrition and health: current knowledge and future perspectives. IDF Document. (In press)Google Scholar
  14. Gasser F (1994) Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull. Inst. Pasteur 92: 45–67Google Scholar
  15. Giraffa G, Carminati D and Neviani E (1997) Enterococci isolated from dairy products: a review of risks and potential technological use. J. Food Protect. 60: 732–738Google Scholar
  16. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L and Salminen S (1992) Survival of Lactobacillus species (Strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 37: 121–128Google Scholar
  17. Guarner F and Schaafsma GJ (1998) Probiotics. Int. J. Food Microbiol. 39: 237–238Google Scholar
  18. Hamilton-Miller JMT, Shah S and Smith CT (1996) Probiotic’ remedies are not what they seem. Brit. Med. J. 312: 55–56 Hamilton-Miller JMT, Shah S and Winkler JT (1999) Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr. (in press)Google Scholar
  19. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y and Takano T (1996) A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Amer. J. Clin. Nutr. 64: 767–771Google Scholar
  20. Havenaar R and Huis in’t Veld JHJ (1992) Probiotics: a general view. In: Wood BJB (Ed.) The lactic acid bacteria: Vol. I The lactic acid bacteria in health and disease. (pp 151–170 ). Elsevier Applied Science, LondonCrossRefGoogle Scholar
  21. Holzapfel WH, Haberer P, Snel J, Schillinger U and Huis in’t Veld JHJ (1998) Overview of gut flora and probiotics. Int. J. Food Microbiol. 41: 85–101Google Scholar
  22. Hosono A, Lee J, Ametani A, Natsume M, Hirayama M, Adachi T and Kaminogawa S (1997). Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101–4. Biosci. Biotech. Biochem. 61: 312–316Google Scholar
  23. Huis in’t Veld JHJ and Havenaar R (1997) Selection criteria and application of probiotic microorganisms in man and animal. Microccol. Ther. 26: 43–57Google Scholar
  24. Jett BD, Huycke MM and Gilmore MS (1994) Virulence of enterococci. Clin Microbiol. Rev. 7: 462–478Google Scholar
  25. Kampman E, Goldbohm RA, van den Brandt PA and van’t Veer P (1994) Fermented dairy products, calcium and colorectal cancer in the Netherlands cohort study. Cancer Res. 54: 3186–3190Google Scholar
  26. Kurtzweil P (1998) Staking a claim to good health. FDA and science stand behind health claims on foods. FDA Consumer, Nov-Dec. Google Scholar
  27. Langseth L (1996) Nutritional epidemiology: possibilities and limitations. TLS] Press, Washington, DCGoogle Scholar
  28. Maeno M, Yamamoto N and Takano T (1996) Identification of antihypertensive peptides from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 73: 1316–1321CrossRefGoogle Scholar
  29. Marin ML, Lee JH, Murtha J, Ustunol Z and Pestka JJ (1997) Differential cytokine production in clonal macrophage and T-cell lines cultured with bifidobacteria. J. Dairy Sci. 80: 2713–2720PubMedCrossRefGoogle Scholar
  30. Marteau P, Minekus M, Havenaar R and Huis in’t Veld JHJ (1997) Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effect of bile. J. Dairy Sci. 80: 1031–1037PubMedCrossRefGoogle Scholar
  31. McNamara SH (1998) So you want to market a food and to make health-related claims — How far can you go? What rules of law will govern the claims you want to make? Food Drug Law J. 53: 421–436PubMedGoogle Scholar
  32. Micanel N, Haynes IN and Playne MJ (1997) Viability of probiotic cultures in commercial Australian yogurts. Aust. J. Dairy Technol. 52: 24–27Google Scholar
  33. Millar MR. Bacon C, Smith SL, Walker V and Hall MA (1993) Enteral feeding of premature infants with Lactobacillus GG. Arch. Dis. Childhood 69: 483–487Google Scholar
  34. Minekus M, Smeets-Peeters M, Bernalier A, Marol S, Havenaar R, Marteau P, Alric M, Fonty G and Huis in’t Veld JHJ (1999) A computer-controlled model of the large intestine with peristaltic mixing, absorption of fermentation products and a high-density microflora. (in press)Google Scholar
  35. Minekus M, Marteau P, Havenaar R and Huis in’t Veld JHJ (1995) A multicompartmental dynamic computer-controlled model sim-ulating the stomach and small intestine. ATLA (Alternative To Laboratory Animals) 23: 197–209Google Scholar
  36. Molin G, Jeppsson B, Johansson M-L, Ahrne S, Nobaek S, Stahl M and Bengmark S (1993) Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. J. Appl. Bacteriol. 74: 314–323Google Scholar
  37. Monique GLe, Moulton LH, Hill C and Kramar A (1986) Consumption of dairy produce and alcohol in a case-control study of breast cancer. J. Nat. Cancer Instit. 77: 633–636.Google Scholar
  38. Noble WC, Virani Z and Cree RGA (1992) Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93: 195–198Google Scholar
  39. Perdigon G, Nader de Macias ME, Alvarez S, Oliver G and Pesce de Ruiz Holgado AA (1986) Effect of perorally administered lactobacilli on macrophage activation in mice. Infect. Immun. 53: 404–410Google Scholar
  40. Peters RK, Pike MC, Garabrant D and Mack TM (1992) Diet and colon cancer in Los Angeles County, California. Cancer Causes and Control 3: 457–473Google Scholar
  41. Reuter G (1997) Present and future of probiotics in Germany and in Central Europe. Biosci. Microflora 16: 43–51Google Scholar
  42. Roberfroid MB (1998) Prebiotics and synhiotics: concepts and nutritional properties. Brit. J. Nutr. 80: 5197–S202Google Scholar
  43. Salminen S, von Wright A, Morelli L, Marteau P, Brassart D. de Vos WM, Fonden R, Saxelin M, Collins K, Mogensen G, Birkeland S-E and Mattila-Sandholm T (1998). Demonstration of safety of probiotics — a review. Int. J. Food. Microbiol. 44: 93–106Google Scholar
  44. Salminen S, Isolauri E and Salminen E (1996) Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains for future challenges. Antonie Van Leeuwenhoek 70: 347–358PubMedCrossRefGoogle Scholar
  45. Sanders ME (1998) Development of consumer probiotics for the US market. Brit. J. Nutr. 80: S213–S218PubMedGoogle Scholar
  46. Sanders ME, Walker DC, Walker KM, Aoyama K and Klaenhammer TR (1996) Performance of commercial cultures in fluid milk applications. J. Dairy Sci. 79: 943–955PubMedCrossRefGoogle Scholar
  47. Savaiano DA, AbouElAnouar A, Smith DE and Levitt MD (1984) Lactose malabsorption from yogurt, pasteurized yogurt, sweet acidiohilus milk, and cultured milk in lactase-deficient individuals. Amer. J. Clin. Nutr. 40: 1219–1223Google Scholar
  48. Saxelin M, (1997) Lactobacillus GG — a human probiotic strain with thorough clinical documentation. Food Rev. Int. 13: 293–313Google Scholar
  49. Saxelin M, Rautelin H, Salminen S and Makela PH (1996a) Safety of commercial products with viable lactobacillus strains. Infect. Dis. Clin. Pract. 5: 331–335Google Scholar
  50. Saxelin M, Chuang MH, Chassy B, Rautelin H, Makela PH, Salminen S and Gorbach SL (1996b) Lactobacilli and bacteremia in southern Finland, 1989–1992. Clin. Infect. Dis. 22: 564–566Google Scholar
  51. Solis Pereyra B and Lemonnier D (1993) Induction of human cytokines by bacteria used in dairy foods. Nutr. Res. 13: 1127–1140CrossRefGoogle Scholar
  52. Spanhaak S, Havenaar R and Schaafsma G (1998) The effect of consumption of milk fermented by Lactobacillus easel strain Shirota on the intestinal microflora and immune parameters in humans. Europ. J. Clin. Nutr. 52: 899–907Google Scholar
  53. Storlie J, O’Flaherty MJ and Hare K (1998) Food or Supplement? Choosing the appropriate regulatory path. Food Technol. 52: 6269Google Scholar
  54. Tannock GW (1999) Probiotics: A critical review. Horizon Press, Wymondham (Norfolk), UKGoogle Scholar
  55. Tannock GW (1998) Studies of the intestinal microflora: a prerequisite for the development of probiotics. Int. Dairy J. 8: 527–533CrossRefGoogle Scholar
  56. Titze A, Kuhn C, Lorenz A, de Vrese M and Barth C (1996) The influence of viable lactobacilli on lactose degradation in the gut of gnotobiotic animals. XIIth International Symposium on Gnotobiology, Honolulu, pp. 43Google Scholar
  57. Tomera JF (1996) Yogurt: probiotic pharmacology. Drugs of Today 32: 539–551Google Scholar
  58. Tomioka H and Saito H (1992) Lactic acid bacteria in the support of immuno-compromised hosts. In: Wood BJB (Ed.) The lactic acid bacteria: Vol. I The lactic acid bacteria in health and disease. (pp 263–296 ) Elsevier Applied Science, LondonCrossRefGoogle Scholar
  59. van’t Veer P, Dekker JM, Lamers JWJ, Kok FJ, Schouten EG, Brants HAM, Sturmans F and Hermus RJJ (1989) Cancer Res. 49: 40204023Google Scholar
  60. Vesa TH, Marteau Ph, Zidi S, Briet F, Pochart Ph and Rambaud JC (1996) Digestion and tolerance of lactose from yoghurt and different semi-solid fermented dairy products containing Lactobacillus acidophilus and bifidobacteria in lactose maldigesters — Is bacterial lactase important? Euro. J. Clin. Nutr. 50: 730–733Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1999

Authors and Affiliations

  1. 1.Dairy and Food Culture TechnologiesLittletonUSA
  2. 2.Dairy Products Technology CenterCalifornia Polytechnic State UniversitySan Luis ObispoUSA
  3. 3.School of Veterinary MedicineUtrecht UniversityUtrechtThe Netherlands
  4. 4.Yakult Europe B.V.Prof. J.H. Bavincklaan 5AmstelveenThe Netherlands

Personalised recommendations